Vitiligo is a skin condition in which loss of skin color (pigment) causes white patches to develop on the skin. Any part of the body may be affected, but it most commonly appears on exposed areas of skin, around the armpits and groin, at injury sites or around moles.
While vitiligo can occur in people of all ethnicities, it is often more noticeable in people with darker skin. It can also start at any age, but tends to first appear between the ages of 10-30 years. Vitiligo is not an infection and cannot be passed on from one person to another.
Entry into the body of microorganisms that can reproduce and cause disease.
Vitiligo occurs when melanocytes in the skin are damaged or destroyed. Melanocytes are cells that produce melanin, the pigment responsible for determining the color of your skin, hair and eyes. The characteristic white patches of vitiligo occur when there are very few or no melanocytes producing melanin in an area of skin. Vitiligo is not caused by an infection and is not contagious.
Vitiligo is characterized by white patches of skin that lack melanin.
While it is not known exactly why melanocytes are lost from the skin, some proposed causes include:
The immune system may mistakenly attack melanocytes, as if fighting infection or healing a wound. This damages the melanocytes and causes absence of melanin in affected areas of skin. Vitiligo can also be associated with other autoimmune conditions, such as Addison's disease, hyperthyroidism, vitamin B12 deficiency (pernicious anemia) and a particular type of hair loss, known as alopecia areata.
Defective nerve cells in the skin release toxic substances or neurochemicals that harm nearby melanocytes. This process may result from continuous friction or injury to the skin.
Another theory is that melanocytes may destroy themselves due to unknown reasons. This self-destruction is known as an autotoxic response.
Given that vitiligo tends to run in families, certain genetic factors passed on from parents to their children are thought to make melanocytes more vulnerable.
Several factors are known to trigger vitiligo without directly causing it. For example, vitiligo may occur after physical or emotional stress, childbirth, exposure to certain chemicals, cancer of the melanocytes (melanoma), or a skin injury such as a cut or severe sunburn. Vitiligo appearing at the site of an injury is known as the Koebner response.
A chronic condition in which the adrenal glands are damaged, leading to a reduction of the hormones cortisol and/or aldosterone. These hormones are important for daily bodily functions and their deficiency can lead to a wide variety of symptoms.
Entry into the body of microorganisms that can reproduce and cause disease.
A condition in which the body cannot produce enough red blood cells due to a lack of vitamin B12.
A water-soluble vitamin needed for protein and DNA synthesis, metabolism of folate and red blood cell production.
Risk factors that increase the likelihood of developing vitiligo include:
Cancer of the white blood cells that primarily involves the skin.
Vitiligo may be classified into the following types:
Non-segmental vitiligo (NSV) is the most common type, affecting both sides of the body in a symmetrical pattern. For example, it may develop on both of the hands or knees. In its early stages, NSV often appears on the backs of the hands, arms, elbows, feet or knees. It may start with a rapid loss of skin color, followed by a period of inactivity, then further color loss. As this cycle continues over time, white patches become larger and more noticeable.
Segmental vitiligo (SV) describes white patches that usually only occur on one area of the body, such as a leg or the face. Some people with this type of vitiligo may also lose color in the hair of the scalp, eyebrows, eyelashes or beard. SV often begins at an early age, progresses for about a year and then stops.
While quite rare, mixed vitiligo involves a combination of non-segmental and segmental vitiligo symptoms.
The unclassified description is used during early stages of vitiligo when symptoms are still developing.
Vitiligo usually first appears as a few small white patches that may then spread over several months. It can occur on any part of the body, but usually begins on the hands, feet, forearms and face. Vitiligo can also affect the eyes, ears or linings of the mouth, nose, rectum and genitals.
It is hard to predict how vitiligo symptoms will progress. In some people, the characteristic white patches grow and spread, but stay in the one area for a number of years. However, it is also possible for symptoms to shift and change over time as areas of skin lose and then regain color. Symptoms can also range from one or a few white patches to a widespread loss of color.
In general, symptoms may include:
These symptoms aside, vitiligo doesn't cause other signs of illness or skin changes, such as dryness or soreness. However, affected skin may occasionally be itchy and the lack of color makes sunburn more likely.
Your doctor will usually diagnose vitiligo by examining the skin and asking questions about your personal and family medical history. To confirm the diagnosis, your doctor may also use a handheld ultraviolet (UV) light, known as a Wood's light, which makes white areas of vitiligo glow in the dark.
Sometimes your doctor may also take a small skin or blood sample to rule out other causes or check for autoimmune conditions. If the eyes are affected by vitiligo, you may be referred to an eye specialist (ophthalmologist) for further tests.
As there is no known cure for vitiligo, treatment aims to improve the skin's appearance by restoring color or making symptoms less noticeable. However, if vitiligo symptoms are of little concern or are not visible to others, treatment may be avoided altogether. Options for treatment may include:
To help protect against sunburn and skin damage, it is recommended that you cover your skin when outdoors, stay out of the sun and use sunscreen with a sun protection factor (SPF) of 30 or higher.
As sunlight is the body's main source of vitamin D, you may be prescribed supplements to avoid problems arising from reduced exposure to sunlight.
To hide symptoms of vitiligo, your doctor may recommend a special camouflage cream made to match your skin tone. These creams are usually waterproof, last for hours and can be applied to any area of the body. Some creams may also contain sunscreen for added skin protection. Similarly, self-tanning products may also be used to help cover vitiligo.
To block the autoimmune response thought to cause vitiligo, your doctor may prescribe a corticosteroid cream, such as betamethasone, hydrocortisone or fluticasone. These medications can prevent the spread of white patches or even restore natural skin color in some people.
However, corticosteroids can cause side effects, such as thinning of the skin, acne or a red skin rash. For this reason, they are usually only prescribed for less than three months at a time, when sun protection and skin camouflage measures have not helped. Corticosteroid creams are not recommended for sensitive areas, such as the face and neck.
Also known as calcineurin inhibitors, these medications may be particularly useful for treating vitiligo on the face and neck, where corticosteroid creams are not usually used. These medications may restore skin color, possibly by blocking the autoimmune response thought to cause vitiligo. Immunosuppressant creams used to treat vitiligo include tacrolimus and pimecrolimus.
Also known as phototherapies, these treatments are only recommended when symptoms are widespread, or previous treatments have not worked. Used alone or together with medications, these treatments are designed to restore skin color through the use of artificial light. Types of light therapies used for vitiligo include:
Narrowband ultraviolet B (UVB) therapy involves controlled application of UVB light to the skin from an artificial light source. As the light is delivered at a narrow wavelength, it can be targeted to a very small area of vitiligo. Treatment usually involves two sessions per week and may be given together with immunosuppressant medication.
Light therapy for vitiligo.
Photochemotherapy involves administration of a light-sensitizing medication, psoralen, prior to application of ultraviolet A (UVA) light. As UVA light is delivered at a longer wavelength than narrowband UVB light, it is not as targeted but can reach deeper into the skin. It is most effective on the face and body rather than on the hands and feet.
During PUVA treatment, light is applied for a few minutes using a specialized machine at a hospital or clinic. The treatment is usually given twice a week for up to two years. Treated patches turn pink at first and then begin to return to original skin color as they heal. Side effects can include sunburn, blistering, itching, or areas of skin turning particularly dark.
A device, known as an excimer laser, can deliver a narrow wavelength of UVB light to a very precise area of skin. Excimer laser treatment is often given together with cream medications. Possible side effects may include redness and blistering.
In some cases, a surgical procedure at a specialized clinic may be suggested to reduce the appearance of vitiligo. Surgical treatment options might include:
Skin grafting surgery involves taking normal skin from one area of the body and using it to cover a patch of vitiligo. A number of techniques may be used for removing the skin, including dermabrasion, laser treatment, a skin punch, or blistering using suction or dry ice (liquid nitrogen). Possible side effects include pain, infection or temporary development of skin patches that are particularly dark or light.
Tattooing may be suggested by your doctor as a method for returning color to the skin, particularly around the lips or in people with dark skin. Also known as micropigmentation, the procedure is conducted with a specialized surgical instrument. Tattooing procedures are generally recommended when the spread of vitiligo has stabilized.
Another surgical procedure, known as autologous melanocyte transplant, involves taking a sample of normal skin and using it to grow new melanocytes in a laboratory. These melanocytes are then transplanted to areas of skin affected by vitiligo, where they begin to produce new melanin. However, this treatment is not widely available and is usually expensive.
For dark skin or when large areas are affected by vitiligo, depigmentation therapy may be an option. This treatment involves applying a medication called monobenzene ester of hydroquinone to normal skin. This medication reduces the amount of pigment, so that unaffected skin becomes the same color as areas of vitiligo. Possible side effects may include redness, swelling and ongoing sensitivity to sunlight. As depigmentation therapy is permanent, this option is usually only recommended if other treatments have not worked.
Entry into the body of microorganisms that can reproduce and cause disease.
An indication of the level of protection a sunscreen provides against ultraviolet A and B light when applied correctly.
A vitamin that is important for the health of bones and teeth as it promotes absorption of calcium from the diet.
While vitiligo does not develop into other conditions, it may lead to the following complications:
Due to a lack of melanin, people with vitiligo are at increased risk of sunburn. White skin affected by vitiligo does not tan; it can only burn. Similarly, exposing unaffected skin to sunlight can cause vitiligo to spread or become more noticeable.
As vitiligo often affects exposed skin over a long period, the condition may lead to psychological issues, such as embarrassment, social withdrawal, low self-esteem or depression.
Vitiligo can cause changes to the retina and some variation in the color of the iris. In some cases, there can also be inflammation of the retina or iris but vision is usually not affected.
A body’s protective immune response to injury or infection. The accumulation of fluid, cells and proteins at the site of an infection or physical injury, resulting in swelling, heat, redness, pain and loss of function.
A colored, disc-shaped membrane located in the front of the eye, which controls the size of the pupil, to help focus light at the back of the eye.
Vitiligo is unpredictable and affects people in different ways. Young people with stable vitiligo on the face usually have the best chance of regaining skin color. Vitiligo that appears later in life on the limbs, hands and lips is less likely to respond well to treatment. A stage of color loss may be followed by a stable period where the skin does not change. These cycles may continue for life.
Treatment outcomes are also variable. For example, treated skin may be lighter or darker than normal skin, or it may respond differently to sunlight. Even when treatment is successful, symptoms may reappear later in a treated or untreated area. However, as vitiligo does not cause pain or develop into other conditions, treatment may not be required if symptoms do not cause distress.
There is no known way to prevent vitiligo from developing or progressing. However, various treatments may improve the skin's appearance by restoring color or making symptoms less noticeable. Protecting affected skin from sunlight may help to prevent sun damage.